Lyophilization process development
A comprehensive process development, all performed in-house
For many fragile (bio)pharmaceutical drug substances, lyophilization is the method of choice to achieve a stable drug product.
As lyophilization is an expensive process, it is of high importance to develop economical freeze-drying cycles suitable for large-scale production.
At Coriolis Pharma we are highly experienced in the development, optimization, scale-up and transfer of lyophilization cycles for (bio)pharmaceutical drug products. In our 400 m² lyophilization development center we can lyophilize different products like
- protein-based formulations (including highly concentrated formulations)
- organic solvent containing formulations or
- live virus vaccines under Biosafety level 1 or 2
in different packaging formats like vials, cartridges and bulk trays.
Explore our capabilities regarding lyophilization process development and get in contact with our experts today.